Interested in stem cell developments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And they are established Big Pharma with considerable clout.
A great statement here, urgonnatrip.
Carl Solomon was an unemployed stagehand at one time.
Yo aGuy, I posted the question about Templeton, MA. I did that because I know it is a small town, about 8000 population and seemed unlikely to even have an RT or NeuroRX filing cabinet never mind an office. It is about 50 mi. from Framingham so could be someone working at the office in Framingham while living in Templeton. In any case, good research here.
Andy2018, doesn't that make aviptadil a cure?
Let's hope their heads are not so far up their asses on this one.
Whaat is the answer?
Anyone know why this link lists Relief Therapeutics or the post coming from Templeton, MA?
This is like the Trump difference on the price to build and the presumed selling price. For Trump the former is the value for IRS reporting and the latter is for getting loans or bragging about personal worth.is
There is an outside chance Trump may push it ahead anyway, as a last minute claim to a cure or tremendous therapeutic, in hopes of pulling out an election victory.
I think that would not help Trump much and I also think, if it happened, it would not hurt RLF100 because it will stand on the genuine data whenever that starts to get attention.
TechWatch Meeting Benefits
Receive feedback from USG experts
Hear techniques and strategies for addressing technical and regulatory challenges
Get insight on how your solution could fit within the Government
Better prepare you for a formal proposal submission
Note: TechWatch submissions are not considered for potential funding
But labels added incorrectly.
Yes, in that interview Javitt did also say that PhaseBio was targeting the VPAC2 receptor in the blood vessels.
Dr Javitt does say in his Sep 30, 2020 interview with Dr Yo that Aviptadil targets the VPAC1 receptor that is in the lung as opposed to the VPAC2 receptor that is in the blood vessels.
The labels {VPAC1} and {VPAC2} have been added in here and are not on the website version of this statement. Are these labels correctly placed here?
Very good clip here.
Trump got remarkably better very quickly and mentioned having lung problems that cleared up in a few days. It sounds very much like the course of treatment for the RLF100 patients. Still, it is, no doubt, too good to be true and a very long shot to hope that RLF100 was used on him.
pegs1, many are saying and I can guarantee you this, I AM THE LEAST RACIST PERSON ON IHUB.
KILLZILLA made a "brainless" statement. Why would he suggest states, in particular NY and CA, might ban medications that could save countless lives. That is just straight out nonsense and, of course fits Trump's attacks on Govs. Cuomo and Newsome who have been far more articulate than him (not a hard thing to do) on COVID issues and needs.
Very nice. Sami Said does deserve attention and Javitt is very happy to give him his due.
Yes, no one is going to risk solid reputations playing games here, especially with a pandemic raging. Some of them may even think this complicated venture could one day yield a Nobel Prize somewhere in there and that woud have them toeing the line very carefully.
Yes, but he may well have been meeting with his Rabbi about Yom Kippur issues. Still, it is true that we investors were allowed to conclude that as a result of that big news might be coming before the Dr. Yo interview. In any case, that was purely a one day phenomenon.
Well, now, that remains to be seen. It has produced incredible gains once and may do it again soon and you may have to swallow your "lol" but for the moment I am laughing with you.
Very nice work here Uncle.
The question now prevailing: Is there anything Aviptadil doesn't improve?
Yes. Good statement.
Nice article.
In fact, that section is what left me unsure about the formulation of Aviptadil. It says "...a natural agonist that acts on both VPAC1 and VPAC2 receptors may present interesting advantages over selective VPAC2 agonists by having a more complete spectrum of action, on immune and lung cells." It was not clear to me whether a natural agonist was being added to synthetic VIP or it was referring to VIP as the natural agonist. The latter seems like strange phrasing but it may be a matter if definition. Elsewhere the following is stated "Relief also holds a patent issued in the U.S. and multiple other countries covering potential formulations of RLF-100." It would seem to be the case that different formulations of RLF100 have to refer to different properties being added to the synthetic VIP and not that there are different formulations of synthetic VIP.
Not at all. No snippy at me. On the other hand, I may have to give you a bit of credit for that.
I know Aviptadil is a synthetic form of VIP and thought I had implied that. It is the synthetic forms of VIP that add agonists to increase their half-life. Aviptadil does include at least one agonist that, I believe, acts on both VPAC1 and VPAC2 receptors.
VIP has a half-life of 2 min. Synthetic VIP formulations add agonists which increase the half-life. The highest I have seen is 19.5 min. For the moment, I have not been able to pin down the half-life of Aviptadil, either IV or inhaled form..
Excellent segment on Aviptadil
This does make RLF100 a bit more likely to shock the world.
I don't understand why this argument is going back and forth, on and on. The decision will be made by the DSMB and the FDA. They can decide when and how they will look at the data. If any studies are being shortened I would think it would not be done because of overconfidence but very much on the basis of feedback being given by the FDA. Also, they will have the benefit of having the data to analyze rather than making guesses which is the best anyone here can do.
I accept. I love Kubrick too.
You might not be kidding.